Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Pharmaceutical Research|December 1, 1994
Menthol-beta-D-glucuronide: a potential prodrug for treatment of the irritable bowel syndromeH W Nolen, D R FriendPharmaceutical Development and Technology|September 22, 1998
Purified guar galactomannan as an improved pharmaceutical excipientM S Gebert, D R FriendJournal of Pharmaceutical Sciences|June 1, 1995
Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitisH Nolen, R N Fedorak, D R FriendGut|October 1, 1994
A budesonide prodrug accelerates treatment of colitis in ratsN Cui, D R Friend, R N FedorakBiopharmaceutics & Drug Disposition|November 28, 1997
Steady-state pharmacokinetics of corticosteroid delivery from glucuronide prodrugs in normal and colitic ratsH W Nolen, R N Fedorak, D R FriendDrug Design and Delivery|October 1, 1990
Effect of antibiotic pretreatment on glycoside/glycosidase-based colonic drug deliveryD R Friend, J J Chow, G W ChangFood and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 1, 1991
Cutaneous effects of transdermal levonorgestrelD R Friend, S J Phillips, J R HillJournal of Pharmaceutical Sciences|September 1, 1994
Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contentsA D McLeod, D R Friend, T N TozerThe Journal of Pharmacy and Pharmacology|May 1, 1991
Relative anti-inflammatory effect of oral dexamethasone-beta-D-glucoside and dexamethasone in experimental inflammatory bowel disease in guinea-pigsD R Friend, S Phillips, A McLeod, et al.Pharmaceutical Research|November 1, 1993
In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug deliveryB Haeberlin, W Rubas, H W Nolen, et al.Pageof 4